跳至主要内容
临床试验/RBR-8m3htgm
RBR-8m3htgm尚未招募Unknown

Evaluation of supraphysiological doses of Testosterone in patients with castration-resistant prostate Adenocarcinoma without metastases

niversidade do Estado do Rio de Janeiro0 个研究点开始时间: 2023年9月17日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 75Y(—)
性别
Male

入选标准

  • Patients between 18 and 75 years old; diagnosis of prostate adenocarcinoma without neuroendocrine differentiation or unconventional subtypes; resistant to surgical or medical castration; not metastatic; PSA doubling time < 10 months

排除标准

  • Patients with PS > 2; Presence of moderate to severe organic dysfunctions related, among others, to liver, kidney or heart function; Uncontrolled primary prostatic disease; Presence of previous or current diagnosis of another neoplasm except non-melanoma skin cancer; Positive pelvic node disease, considered as any pelvic lymph node larger than 2.0 cm in the shortest axis

研究者

发起方
niversidade do Estado do Rio de Janeiro

相似试验